About Conference

The 5th Global Congress on Neuroscience, Psychiatry, and Mental Disorders is a premier international event bringing together leading experts, researchers, and practitioners in the fields of neuroscience and mental health which is scheduled on March 13-14, 2025 in Paris, France. Focused on the latest advancements and challenges, the congress fosters interdisciplinary discussions on brain science, innovative treatments, and mental health care strategies. This platform encourages the exchange of ground-breaking ideas, promoting global collaboration to enhance understanding and address pressing issues in mental disorders and psychiatric care. Attendees will have the opportunity to network with global peers, explore innovative therapeutic approaches, and gain insights into emerging trends shaping the future of neuroscience and psychiatry. This congress is an invaluable platform for fostering collaboration and driving meaningful progress in addressing mental health challenges worldwide.

Targeted Audience

• Neurologists
• Psychiatrists
• Mental Health Practitioners
• Researchers and Academics
• General Physicians
• Students and Trainees
• Advocacy Groups and Non-profits
• Technology Developers
• Bioethicists and Legal Professionals
• Veterans' Health Experts

Sessions & Tracks

Track 1: Neuroscience

Neuroscience is the scientific study of the nervous system, encompassing the brain, spinal cord, and neural networks that control thoughts, emotions, behavior, and bodily functions. This interdisciplinary field combines biology, psychology, chemistry, and physics to understand how the brain processes information, adapts, and influences the body. Neuroscience plays a critical role in unraveling the mysteries of conditions like Alzheimer's, Parkinson's, epilepsy, and mental health disorders. Advances in neuroimaging, neurogenetics, and brain-computer interfaces are transforming our ability to diagnose, treat, and enhance brain function, fostering innovation in healthcare, technology, and beyond.

Track 2: Neurogenesis

Neurogenesis is the study of the relationship between genetics and the nervous system, focusing on how genes influence the development, function, and disorders of the brain and nervous system. This interdisciplinary field combines insights from genetics, neuroscience, and molecular biology to understand hereditary neurological conditions like Huntington's disease, Alzheimer's, and epilepsy, as well as complex disorders such as autism and schizophrenia. Advances in neurogenetics are paving the way for personalized medicine, enabling tailored treatments based on an individual's genetic profile, and shedding light on the genetic underpinnings of brain function and behavior.

Track 3: AI in Brain Research

Artificial intelligence (AI) is revolutionizing brain research by enabling more precise analysis, prediction, and understanding of complex neurological and psychiatric conditions. AI algorithms, particularly machine learning, are being used to process large datasets from neuroimaging, genomics, and electrophysiology to identify patterns that were previously undetectable. These technologies aid in early diagnosis, personalized treatment plans, and drug discovery by simulating brain activity and predicting disease progression. AI also enhances neuroplasticity research and cognitive rehabilitation through advanced brain-computer interfaces (BCIs).

Track 4: Mood Disorders

Mood disorders are a group of mental health conditions primarily characterized by disturbances in a person’s emotional state. These disorders include depression, where individuals experience persistent sadness and loss of interest, and bipolar disorder, marked by extreme mood swings between depression and mania. Other mood disorders may involve cyclothymia (mild mood fluctuations) and persistent depressive disorder (also known as dysthymia). These are often linked to a combination of genetic, environmental, and biological factors, including imbalances in neurotransmitters, hormones, and brain structure. Treatment options typically include psychotherapy, medications such as antidepressants and mood stabilizers, and lifestyle changes. Early detection and comprehensive management are essential in improving outcomes and quality of life for those affected.

Track 5: Global Mental Health

Global Mental Health refers to the international effort to address mental health issues across diverse populations, recognizing that mental health is a universal concern that affects individuals worldwide. With approximately 1 in 8 people globally affected by mental disorders, there is an urgent need for increased awareness, access to care, and resources. The global mental health movement seeks to reduce the stigma surrounding mental health, promote equitable access to mental health services, and advocate for the integration of mental health into public health systems. Key challenges include addressing mental health disparities in low- and middle-income countries, providing culturally competent care, and combating the rising mental health burden due to factors like the COVID-19 pandemic, conflict, and climate change.

Track 6: Addiction Psychiatry

Addiction Psychiatry is a specialized branch of psychiatry focused on the diagnosis, treatment, and prevention of substance use disorders (SUDs) and behavioral addictions. It addresses the complex interplay between psychological, biological, and social factors that contribute to addiction, aiming to understand the underlying neurobiological mechanisms, patterns of substance abuse, and compulsive behaviors. Addiction psychiatrists employ a range of therapeutic strategies, including pharmacotherapy, psychotherapy, and behavioral interventions.

Tack 7: Autism

Autism, or Autism Spectrum Disorder (ASD), is a complex neurodevelopmental condition characterized by differences in social interaction, communication, and behavior. It affects individuals to varying degrees and is often diagnosed in early childhood. People with autism may exhibit repetitive behaviors, restricted interests, and challenges in interpreting social cues. The causes of autism are not fully understood, though a combination of genetic and environmental factors is believed to contribute. Early diagnosis and intervention, including behavioral therapies, speech therapy, and educational support, can significantly improve outcomes, helping individuals lead fulfilling lives. Advances in research continue to explore the underlying neurological mechanisms, potential treatments, and strategies to enhance the quality of life for those with autism.

Track 8: Post-Traumatic Stress Disorder (PTSD)

Post-Traumatic Stress Disorder (PTSD) is a mental health condition triggered by experiencing or witnessing traumatic events, such as natural disasters, accidents, military combat, or abuse. Individuals with PTSD may experience flashbacks, nightmares, severe anxiety, and emotional numbness, which can interfere with daily life and relationships. Symptoms often develop within a few months of the trauma but can appear years later. PTSD affects both mental and physical health, contributing to issues such as depression, substance abuse, and chronic pain. Early intervention through therapy (including Cognitive Behavioral Therapy and EMDR) and medications can be effective in managing symptoms and improving the quality of life for those affected by PTSD.

Track 9: Schizophrenia and Psychotic Disorders

Schizophrenia and psychotic disorders are severe mental health conditions characterized by distorted thinking, perception, and behavior, often leading to a loss of touch with reality. Schizophrenia, the most well-known psychotic disorder, typically manifests in early adulthood and is marked by symptoms such as hallucinations, delusions, disorganized speech, and impaired cognitive function. Treatment usually involves a combination of antipsychotic medications, psychotherapy, and support systems to manage symptoms. Despite advancements in care, schizophrenia and psychotic disorders continue to present significant challenges in diagnosis, treatment, and long-term management, underscoring the need for continued research and innovation in the field.

Track 10: Child and Adolescent Psychiatry

Child and Adolescent Psychiatry focuses on the diagnosis, treatment, and prevention of mental health disorders in children and teenagers. This specialized field addresses a wide range of conditions, including anxiety, depression, ADHD, autism spectrum disorders, conduct disorders, and eating disorders. Child and adolescent psychiatrists utilize a combination of therapies, including psychotherapy, medication management, and family support, tailored to the developmental needs of young patients. Early intervention is critical, as mental health issues in childhood can have a significant impact on long-term well-being, academic performance, and social development. The field is continuously evolving, with a growing emphasis on personalized, evidence-based approaches and interdisciplinary collaboration with educators, pediatricians, and psychologists.

Track 11: Lifestyle Medicine and Brain Health

Lifestyle Medicine and Brain Health focuses on the impact of lifestyle factors such as diet, exercise, sleep, and stress management on brain function and mental well-being. Research has shown that a healthy lifestyle can play a crucial role in preventing or mitigating the onset of neurodegenerative diseases, mood disorders, and cognitive decline. Regular physical activity, a balanced diet rich in antioxidants and omega-3 fatty acids, adequate sleep, and mindfulness practices all contribute to maintaining optimal brain health. Integrating lifestyle interventions into mental health care is increasingly recognized as an effective, non-pharmacological approach to enhance brain function, improve mood, and reduce the risk of neurological disorders.

Track 12: Neuroendocrinology

Neuroendocrinology is the branch of science that studies the interactions between the nervous system and the endocrine system, focusing on how hormones influence brain function and behavior. It explores how the brain regulates the release of hormones through the hypothalamus and pituitary gland, which in turn control vital processes such as stress response, growth, metabolism, and reproduction. Neuroendocrinology is crucial for understanding conditions like depression, anxiety, neurodegenerative diseases, and hormonal imbalances, as it provides insights into how disruptions in hormone signaling can impact mental health and neurological function.

Track 13: Geriatric Psychiatry

Geriatric Psychiatry is a specialized branch of psychiatry that focuses on the mental health needs of older adults. It addresses a range of psychiatric conditions that commonly affect aging populations, such as dementia, Alzheimer's disease, depression, anxiety, and late-life schizophrenia. Geriatric psychiatrists also deal with the complex interplay between psychiatric disorders and medical conditions like cardiovascular diseases, diabetes, and neurodegenerative disorders. Treatment approaches often emphasize a holistic, multidisciplinary approach.

Track 14: Gender Dysphoria

Gender dysphoria is a psychological condition in which an individual experiences significant discomfort or distress due to a mismatch between their assigned gender at birth and their experienced or expressed gender. This incongruence can lead to emotional and psychological challenges, including anxiety, depression, and social isolation. Gender dysphoria is recognized in the DSM-5 (Diagnostic and Statistical Manual of Mental Disorders) and requires clinical attention when it impairs an individual’s functioning or well-being.

Track 15: Spirituality, Mindfulness, and Mental Health

Spirituality, mindfulness, and mental health are increasingly recognized as vital components of holistic care in addressing mental well-being. Spirituality, often tied to personal beliefs and values, can provide individuals with a sense of meaning, purpose, and connection, which has been shown to positively impact emotional resilience and overall mental health. Mindfulness, a practice of focused attention and awareness of the present moment, has been widely researched for its therapeutic effects in reducing stress, anxiety, depression, and improving emotional regulation. Integrating these practices into mental health treatment encourages a more balanced approach, complementing traditional therapies and offering tools for managing symptoms, fostering self-awareness, and promoting long-term well-being. This growing field highlights the importance of nurturing both mind and spirit for comprehensive mental health care.

Track 16: Psychoneuroimmunology

Psychoneuroimmunology (PNI) is an interdisciplinary field that studies the complex interactions between the brain, the nervous system, and the immune system, and how these interactions influence mental and physical health. It explores how psychological processes—such as stress, emotions, and behavior—can affect immune function and, conversely, how immune responses can impact brain activity, mood, and behavior. PNI has significant implications for understanding various mental health disorders, including depression, anxiety, and PTSD, as well as neurodegenerative conditions. Research in this field has paved the way for new approaches to treatment, such as stress management techniques, immunomodulation, and inflammation-targeting therapies.

Track 17: Impulse Control Disorders

Impulse Control Disorders (ICDs) are a group of psychiatric conditions characterized by an inability to resist harmful urges or impulses, leading to behaviors that are often disruptive, damaging, or socially inappropriate. These disorders include conditions such as intermittent explosive disorder, kleptomania (compulsive stealing), pyromania (compulsive fire-setting), gambling disorder, and trichotillomania (hair-pulling disorder). People with ICDs struggle to control impulses, even when they recognize the potential consequences of their actions. Treatment typically involves a combination of psychotherapy (such as cognitive-behavioral therapy), medications (like mood stabilizers or SSRIs), and behavioral interventions aimed at improving impulse regulation and addressing underlying mental health issues.

Track 18: Neuropsychiatric Effects of COVID-19

The Neuropsychiatric effects of COVID-19 have become a significant area of concern, as the pandemic has caused a surge in mental health and neurological disorders. Studies have shown that COVID-19 not only directly impacts the brain through viral infection but also leads to widespread mental health challenges such as anxiety, depression, post-traumatic stress disorder (PTSD), and cognitive impairments, often referred to as "brain fog." Long-term effects, known as "long COVID," include persistent neurological symptoms, such as headaches, memory issues, and sleep disturbances.

Track 19: Dementia Care

Dementia care involves a comprehensive approach to supporting individuals with dementia, focusing on improving quality of life, enhancing cognitive function, and managing symptoms. It includes personalized care plans, which may involve medication, therapeutic interventions, and lifestyle adjustments to manage behavioral and psychological symptoms. Caregivers play a crucial role in providing emotional support, ensuring safety, and maintaining routines that promote cognitive engagement. Effective dementia care also emphasizes a multidisciplinary approach, involving doctors, nurses, social workers, and psychologists to address the physical, emotional, and psychological needs of patients. With the growing global prevalence of dementia, especially among aging populations, there is an increasing focus on developing innovative care models, community-based interventions, and advanced technologies to support both patients and caregivers.

Track 20: Microbiome and Brain Health

The microbiome and brain health are increasingly recognized as interconnected, with growing evidence suggesting that gut microbiota plays a crucial role in brain function and mental well-being. Research in psychobiotics and gut-brain axis interactions has revealed how the microbiome influences mood, cognition, and even the development of neuropsychiatric conditions such as anxiety, depression, and autism. Gut bacteria produce neurotransmitters like serotonin and GABA, which directly impact brain activity. Imbalances in the microbiome, known as dysbiosis, have been linked to neuroinflammation and disruptions in brain signaling, potentially contributing to mental health disorders.

Benefits of Participation

1. Professional Development
2. Skill Enhancement
3. Networking Opportunities
4. Collaborative Opportunities
5. Career Advancement
6. Explore Innovative Therapies
7. Hands-On Experience
8. Contribute to Global Solutions
9. Promote Evidence-Based Practices
10. Shape Future Policies

Market Analysis

The market analysis for the 5th Global Congress on Neuroscience, Psychiatry, and Mental Disorders highlights the rapidly growing demand for advancements in brain research, mental health therapies, and innovative diagnostic tools. With the global burden of mental and neurological disorders projected to increase significantly, the need for cutting-edge solutions is critical. The neuroscience market, valued at approximately $39 billion in 2023, is expected to grow due to breakthroughs in neuroimaging, psychopharmacology, and neuro-technologies. Similarly, the mental health sector has witnessed heightened investment in digital tools and therapeutics, with a compound annual growth rate (CAGR) of 6-8% forecasted through 2030. This congress provides a unique platform for stakeholders to address these market demands, connect with industry leaders, and explore emerging trends that shape the future of neuroscience and mental health care globally.

Visa Trip Advisor

Are you arranging a trip to London, United Kingdom? Come to our gathering!

with your VISA?

We offer participants the following VISA support documents to help them with the VISA application process:

1. Official letter of invitation.

2. Official Acceptance Abstract Letter

3. Payment Acceptance

Please be aware that the official letter of invitation (the visa letter) will not be provided until the conference has been successfully registered and paid for. Only those who have been accepted to the conference are eligible to receive visa letters.

To arrange for a visa letter, please send an email to contact@globalconferencemeet.com  the Programme Manager.

For Visa Letters, kindly provide us with the following information:

The name on your passport, as it appears

Copy of Passport Scan (Passport Number and Birthdate)

Abstract Acceptance Letter Modes of Payment

Payment methods:

1. Payment Gateway: RAZORPAY

2. Bank-to-bank transfer

Having difficulties registering?

Please contact the Program Manager at contact@globalconferencemeet.com. The NEUROSUMMIT 2025 staff will send you an INVOICE for the desired payment, allowing you to complete the Bank-to-Bank transfer.